mRNA |
GSK4112 |
CTRPv2 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.031 |
0.4 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
RDEA119 |
FIMM |
pan-cancer |
AAC |
0.16 |
0.4 |
mRNA |
ABT-263 |
FIMM |
pan-cancer |
AAC |
-0.14 |
0.4 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.4 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
Crizotinib |
FIMM |
pan-cancer |
AAC |
-0.17 |
0.4 |
mRNA |
PF-4708671 |
GDSC1000 |
pan-cancer |
AAC |
0.033 |
0.4 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |